Showing results (291-300 of 1,612) with videos related to
Sort By:
Pageof 162
Spine|April 21, 1999
Molecular biology and spinal disorders. A survey for the clinicianD A Altman, L Titus, G A Hair, et al.Immunity|December 1, 1996
Functional and physical interactions of Syk family kinases with the Vav proto-oncogene productM Deckert, S Tartare-Deckert, C Couture, et al.Immunity|December 10, 1998
Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activationM Deckert, S Tartare-Deckert, J Hernandez, et al.Molecular and Cellular Biology|April 5, 2001
Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoterO Kaminuma, M Deckert, C Elly, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinaseJ Huang, D Tilly, A Altman, et al.Chemical Science|June 24, 2021
Arylation of <i>gem</i>-difluoroalkenes using a Pd/Cu Co-catalytic system that avoids β-fluoride eliminationKedong Yuan, Taisiia Feoktistova, Paul Ha-Yeon Cheong, et al.Biomedical Chromatography : BMC|September 21, 2010
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasmaVidya Perera, Annette S Gross, Andrew J McLachlanJournal of Dental Research|August 10, 1999
Nocturnal masseter EMG activity of healthy subjects in a natural environmentL M Gallo, S S Gross, S PallaDie Rehabilitation|May 7, 2010
[Gender specific differences in coping with colon cancer--empirical findings with special consideration of religious coping]S Murken, S Namini, S Gross, et al.Current Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlanPageof 162